Aisling M. Redmond
- Cancer Research top 10%
- Genetics top 10%
- Estrogen and related hormone effects 7
-
- HER2/EGFR in Cancer Research 4
-
- Genomics and Chromatin Dynamics 4
- RNA Research and Splicing 2
-
- Esophageal Cancer Research and Treatment 3
-
- Chromosomal and Genetic Variations 2
-
- Inflammatory mediators and NSAID effects 2
-
- Advanced Breast Cancer Therapies 1
- Co-authors
- Leonie S. YoungJianming XuYuhui YuanLi QinBert W. O’MalleyHong-Wu ChenLan LiaoJason S. Carroll
- Cited by
- Cancer ResearchGeneticsOncology
- Partner nations
- United KingdomIrelandUnited States
In The Last Decade
Aisling M. Redmond
17 papers receiving 661 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 196
- Genetics 223
- Oncology 200
- Molecular Biology 405
- Immunology and Allergy 23
Countries citing papers authored by Aisling M. Redmond
This map shows the geographic impact of Aisling M. Redmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisling M. Redmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisling M. Redmond more than expected).
Fields of papers citing papers by Aisling M. Redmond
This network shows the impact of papers produced by Aisling M. Redmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisling M. Redmond. The network helps show where Aisling M. Redmond may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aisling M. Redmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 32 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 66 | |
| 5 | 2021 | 39 | |
| 6 | 2020 | 46 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 24 | |
| 9 | 2017 | 48 | |
| 10 | 2016 | 17 | |
| 11 | 2015 | 0 | |
| 12 | 2014 | 30 | |
| 13 | 2011 | 23 | |
| 14 | 2009 | 69 | |
| 15 | 2009 | 20 | |
| 16 | 2008 | 23 | |
| 17 | 2008 | 156 | |
| 18 | 2007 | 53 |
About Aisling M. Redmond
Aisling M. Redmond is a scholar working on Genetics, Cancer Research and Oncology, having authored 18 papers that have together received 665 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (4 papers), Genomics and Chromatin Dynamics (4 papers), Esophageal Cancer Research and Treatment (3 papers), Chromosomal and Genetic Variations (2 papers), Inflammatory mediators and NSAID effects (2 papers), RNA Research and Splicing (2 papers) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (196 citations), Genetics (223 citations) and Oncology (200 citations). Aisling M. Redmond has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Leonie S. Young, Jianming Xu, Yuhui Yuan, Li Qin, Bert W. O’Malley, Hong-Wu Chen, Lan Liao, Jason S. Carroll, Arnold D. Hill and Marie McIlroy. Their work appears in journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.